IGF-doxorubicin conjugate - IGF Oncology
Latest Information Update: 26 Jul 2016
At a glance
- Originator IGF Oncology
- Class Anthracyclines; Cytostatic antibiotics; Doxorubicins; Drug conjugates; Small molecules
- Mechanism of Action DNA intercalators; Type II DNA topoisomerase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 26 Jul 2016 Preclinical trials in Cancer in USA (IV)